US biotech major Gilead Sciences was trading nearly 2% higher in pre-market on Thursday after announcing its third-quarter ...

Maryland-based MacroGenics, a biopharma focused on discovering, developing, manufacturing and commercializing innovative ...

Oncology-focused biotech company Tango Therapeutics announced an update on its PRMT5 program. Tango noted that, based on ...

Moderna posted Q3 2024 revenues of $1.9 billion, up from $1.8 billion in Q3 2023, with net income reaching $13 million, a turnaround from last year’s $3.6 billion loss. Growth was driven by strong US ...